Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Immunome Inc (NASDAQ: IMNM) closed at $6.73 down -3.72% from its previous closing price of $6.99. In other words, the price has decreased by -$3.72 from its previous closing price. On the day, 6.31 million shares were traded. IMNM stock price reached its highest trading level at $6.855 during the session, while it also had its lowest trading level at $6.41.
Ratios:
For a deeper understanding of Immunome Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.08 and its Current Ratio is at 4.08. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on November 08, 2024, initiated with a Overweight rating and assigned the stock a target price of $30.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $27.
On April 30, 2024, JP Morgan started tracking the stock assigning a Overweight rating and target price of $24.JP Morgan initiated its Overweight rating on April 30, 2024, with a $24 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 25 ’25 when BIENAIME JEAN JACQUES bought 7,800 shares for $7.78 per share. The transaction valued at 60,684 led to the insider holds 31,415 shares of the business.
SIEGALL CLAY B bought 137,100 shares of IMNM for $999,459 on Mar 26 ’25. The President and CEO now owns 806,736 shares after completing the transaction at $7.29 per share. On Mar 24 ’25, another insider, BIENAIME JEAN JACQUES, who serves as the Director of the company, bought 7,000 shares for $8.21 each. As a result, the insider paid 57,470 and bolstered with 23,615 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMNM now has a Market Capitalization of 609143040 and an Enterprise Value of 372706912. For the stock, the TTM Price-to-Sale (P/S) ratio is 64.73 while its Price-to-Book (P/B) ratio in mrq is 2.39. Its current Enterprise Value per Revenue stands at 41.224 whereas that against EBITDA is -2.454.
Stock Price History:
The Beta on a monthly basis for IMNM is 2.04, which has changed by -0.685367 over the last 52 weeks, in comparison to a change of 0.077997446 over the same period for the S&P500. Over the past 52 weeks, IMNM has reached a high of $24.86, while it has fallen to a 52-week low of $6.90. The 50-Day Moving Average of the stock is -28.59%, while the 200-Day Moving Average is calculated to be -44.30%.
Shares Statistics:
For the past three months, IMNM has traded an average of 970.69K shares per day and 1939380 over the past ten days. A total of 86.95M shares are outstanding, with a floating share count of 75.42M. Insiders hold about 13.26% of the company’s shares, while institutions hold 61.43% stake in the company. Shares short for IMNM as of 1741910400 were 9523078 with a Short Ratio of 9.81, compared to 1739491200 on 9350699. Therefore, it implies a Short% of Shares Outstanding of 9523078 and a Short% of Float of 11.3800004.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
